Cj. Eagles et U. Martin, NONPHARMACOLOGICAL MODIFICATION OF CARDIAC RISK-FACTORS - PART 3 - SMOKING CESSATION AND ALCOHOL-CONSUMPTION, Journal of clinical pharmacy and therapeutics, 23(1), 1998, pp. 1-9
Smoking cessation (SC) is probably the single most important risk fact
or modification for both primary (1, 2) and secondary (3) prevention o
f cardiovascular disease. Interventions to stop smoking are highly cos
t effective (4). SC produces reductions in mortality and morbidity tha
t generally outweigh any increase in risk due to weight gain, unless t
he gain is so great that it is accompanied by adverse changes in blood
pressure, lipid profile or glucose tolerance. There is clear evidence
that SC improves the lipid profile, decreases thrombotic tendency, re
duces vascular endothelial damage and improves insulin sensitivity. Ep
idemiological studies consistently demonstrate a reduced risk of devel
oping coronary heart disease (CHD) with moderate alcohol consumption (
showing protection at less than or equal to 2 drinks per day), but an
increased risk at higher alcohol consumption levels. Potential mediato
rs of these cardioprotective effects include an increase in high-densi
ty cholesterol (HDL-C), decreased clotting propensity, enhanced insuli
n sensitivity and glucose tolerance, and a possible lowering of blood
pressure at low consumption levels in women. Alcohol consumption may n
ot, however, compensate for the large increase in risk produced by smo
king (5). Whereas moderate alcohol consumption slightly reduces the ri
sk of death between the ages of 35 and 69 years, cigarette smoking app
roximately doubles the risk (5).